China Universal Asset Management Co., Ltd. - LYELL IMMUNOPHARMA INC ownership

LYELL IMMUNOPHARMA INC's ticker is LYEL and the CUSIP is 55083R104. A total of 93 filers reported holding LYELL IMMUNOPHARMA INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 1.4%.

Quarter-by-quarter ownership
China Universal Asset Management Co., Ltd. ownership history of LYELL IMMUNOPHARMA INC
ValueSharesWeighting
Q3 2023$9
-10.0%
6,436
+96.8%
0.00%0.0%
Q2 2023$10
+25.0%
3,271
-3.3%
0.00%0.0%
Q1 2023$8
-11.1%
3,382
+33.5%
0.00%
-25.0%
Q4 2022$9
-99.9%
2,533
+9.1%
0.00%
-42.9%
Q3 2022$17,0002,3210.01%
Other shareholders
LYELL IMMUNOPHARMA INC shareholders Q3 2022
NameSharesValueWeighting ↓
MWG Management Ltd. 20,162,332$29,638,62828.72%
Orland Properties Ltd 15,093,969$22,188,13411.75%
Foresite Capital Management IV, LLC 8,784,813$12,913,6757.17%
MIC Capital Management UK LLP 1,740,569$2,558,6360.58%
Alphabet Inc. 5,865,125$8,621,7330.55%
HSG Holding Ltd 3,045,997$4,477,6160.48%
Clarius Group, LLC 399,168$586,7770.06%
CAXTON ASSOCIATES LP 198,477$291,7610.04%
XTX Topco Ltd 114,720$168,6380.03%
BBR PARTNERS, LLC 164,041$241,1400.03%
View complete list of LYELL IMMUNOPHARMA INC shareholders